Ventus Therapeutics is a company that develops small molecule therapeutics intended to target key innate immune pathways. The company specializes in structure-based drug development to translate structural immunology into a pipeline of novel medicines, enabling medical practitioners to treat autoimmune and autoinflammatory diseases.